The keynote discussion at the beginning of the day will be with MIT Institute Professor Robert Langer who will discuss the creation and commercialization of value in the life sciences industry. Dr. Langer leads the world’s largest biomedical engineering lab, has written more than 1,400 academic articles, and holds over 1,300 patents, many of which have been licensed to over 350 biopharmaceutical, chemical, and medical device companies for commercial use.
Our plenary lunchtime session will feature a panel of General Counsel in the life sciences industry, who will discuss timely litigation issues. In addition, throughout the day, we will hold breakout panel discussions on economics and litigation topics, including:
Finally, the keynote discussion at the end of the day with Kenneth Feinberg, will focus on resolving disputes about value and will address considerations associated with allocating value as well as key lessons learned from settling numerous complex, high-profile litigation matters. Mr. Feinberg is a renowned leader in mediation and alternative dispute resolution who has administered numerous high-profile victim compensation programs (e.g., 9/11 Victim Compensation Fund, Agent Orange Victim Compensation Program, BP Deepwater Horizon oil spill, and the One Fund Boston Victim Relief Fund).
CLE credit is pending in California, Connecticut, Illinois, Missouri, New Jersey, New York, Pennsylvania, Texas, Washington, DC, and Wisconsin.